黏蛋白在乳腺外佩吉特病中的表达及其生物学意义
|
摘要
回顾天津医科大学总医院皮肤科门诊病理室病历资料,了解非良性皮肤肿瘤的发病情况。收集、统计和分析1980年1月至2007年9月天津医科大学总医院皮肤科经病理诊断的非良性皮肤肿瘤的临床资料。共纳入非良性皮肤肿瘤患者531例,男302例,女229例;表皮来源的非良性肿瘤共计414例,占全部的77.97%;主要6种肿瘤的性别构成存在显著差异,皮肤佩吉特病两性患者数量差别最为显著;恶性黑色素瘤患者年龄数据离散程度(四分位数间距32.25)最高,年龄最小患者13岁。非良性皮肤肿瘤和恶性皮肤肿瘤的年诊断例数呈增加的趋势。表皮来源肿瘤是主要的非良性皮肤肿瘤。乳腺外佩吉特病(Extramammary Paget's disease,EMPD)的好发性别,在国人与白色人种之间存在明显差别。警惕恶性黑色素瘤在青少年患者中的发生。
通过检测粘蛋白的表达水平,探索EMPD的肿瘤生物学特性。包括探讨该肿瘤可能的来源;粘蛋白在该肿瘤中的异常表达是否具有特异性,黏蛋白的表达与EMPD淋巴转移的关系。分析E-钙黏蛋白在EMPD中的表达情况,探讨该肿瘤细胞的侵袭转移机制。检测端粒酶在该肿瘤中的活性。采用常规组织病理技术、HE染色、免疫组织化学染色和原位杂交技术。实验数据通过统计分析,发现MUC5AC和E—钙黏蛋白在病例组和对照组中表达存在明显差异。32例患者中有25例表达MUC5AC;E—钙黏蛋白在对照组中全部11例表皮弥漫性表达,但着色强度存在一定差异。而病例组中该蛋白相较对照组存在明显的表达下降,主要表现为染色强度降低,部分病例出现巢状的E—钙黏蛋白表达缺失。本研究中黏蛋白、E—钙黏蛋白的表达、Tert活性与淋巴转移的出现与否、MUC1表达与E—钙黏蛋白表达之间、黏蛋白、E—钙黏蛋白的表达与Tert活性之间没有发现存在关联性。推测MUC5AC在EMPD是一种具有较高特异性的肿瘤标志蛋白。EMPD的肿瘤细胞可能来源于基底细胞层的表皮干细胞。E—钙黏蛋白的在EMPD肿瘤细胞的生长过程中具有重要的生物学意义,这种蛋白的表达下调可能导致了肿瘤的逐渐弥漫性生长。黏蛋白、E—钙黏蛋白的表达、Tert活性之间的关系以及它们与淋巴转移的出现与否之间是否存在联系有待于深入研究。
To investigate the clinical features and changes in the incidence of non-benign Skin Neoplasms in the Department of Dermatology General Hospital of Tianjin Medical University. The patients diagnosed pathologically as non-benign Skin Neoplasms from Jan 1980 to Sep 2007 were retrospectively retrospected. Clinical data of patients were collected and analyzed by statistical methods. There were 531 patients with non-benign Skin Neoplasms diagnosed from 1980 to 2007, including 302 men and 229 women. 414 non-benign Skin Neoplasms from epidermis took the 77.97% of all cases. Six important kinds of all had obviously difference in gender proportion. The difference of skin Paget's disease was the most significant. Vicariance of melanoma patient's age was highest in all cases. The most youngest patient was 13 years. The cases of non-benign and malignant Skin Neoplasms had been increasing in the past 26 years. Neoplasms from epidermis was the main non-benign Skin Neoplasms. There had significant difference in patient gender of extramammary Paget's disease between Chinese and Caucasian. We should pay close attention to probability which youngsters have melanoma.
To analyze the tumor biological character of extramammary Paget's disease by investigate the expression of mucins. The content of research included the histological source of extramammary Paget's disease, and specificity of mucins expression in extramammary Paget's disease, the value in diagnosis and treatment of mucins expression in extramammary Paget's disease, the relationship of mucins expression and lymphatic metastasis of extramammary Paget's disease. By analyzing the E-cadherin expression in extramammary Paget's disease, to discuss the mechanism in invasion and metastasis of Paget's cell. To investigate the activity of human telomerase reverse transcriptase in extramammary Paget's disease. The technique of common histological pathology, HE staining, and immunohistochemistry, hybridization in situ were took in our research. The data of experiment was analyze by statistical method. There were significant difference between extramammary Paget's disease group and contrast group in expression of mucins and E-cadherin. 25 cases of extramammary Paget's disease group had muc5AC expression. All of contrast group had E-cadherin expression, but they had the different expression intensity. The E-cadherin expression intensity in extramammary Paget's disease descended significantly than contrast group. Some cases had focus disappearance in epidermis. In our research, there weren't relation between lymphatic metastasis and expression fo mucins and E-cadherin, between lymphatic metastasis and human telomerase reverse transcriptase activity, between mucl and E-cadherin, between mucins and E-cadherin, between human telomerase reverse transcriptase activity and mucins, between human telomerase reverse transcriptase activity and E-cadherin. Muc5AC maybe one of tumor special protein in extramammary Paget's disease. Paget 's cell maybe from epidermis stem cell in basal cell layer. E-cadherin may be as the important character in extramammary Paget's disease. It's descending may be the reason of Paget's cell widespread. The relation between mucins, E-cadherin and human telomerase reverse transcriptase need continue to research, so as the relation between they and lymphatic metastasis.
通过检测粘蛋白的表达水平,探索EMPD的肿瘤生物学特性。包括探讨该肿瘤可能的来源;粘蛋白在该肿瘤中的异常表达是否具有特异性,黏蛋白的表达与EMPD淋巴转移的关系。分析E-钙黏蛋白在EMPD中的表达情况,探讨该肿瘤细胞的侵袭转移机制。检测端粒酶在该肿瘤中的活性。采用常规组织病理技术、HE染色、免疫组织化学染色和原位杂交技术。实验数据通过统计分析,发现MUC5AC和E—钙黏蛋白在病例组和对照组中表达存在明显差异。32例患者中有25例表达MUC5AC;E—钙黏蛋白在对照组中全部11例表皮弥漫性表达,但着色强度存在一定差异。而病例组中该蛋白相较对照组存在明显的表达下降,主要表现为染色强度降低,部分病例出现巢状的E—钙黏蛋白表达缺失。本研究中黏蛋白、E—钙黏蛋白的表达、Tert活性与淋巴转移的出现与否、MUC1表达与E—钙黏蛋白表达之间、黏蛋白、E—钙黏蛋白的表达与Tert活性之间没有发现存在关联性。推测MUC5AC在EMPD是一种具有较高特异性的肿瘤标志蛋白。EMPD的肿瘤细胞可能来源于基底细胞层的表皮干细胞。E—钙黏蛋白的在EMPD肿瘤细胞的生长过程中具有重要的生物学意义,这种蛋白的表达下调可能导致了肿瘤的逐渐弥漫性生长。黏蛋白、E—钙黏蛋白的表达、Tert活性之间的关系以及它们与淋巴转移的出现与否之间是否存在联系有待于深入研究。
To investigate the clinical features and changes in the incidence of non-benign Skin Neoplasms in the Department of Dermatology General Hospital of Tianjin Medical University. The patients diagnosed pathologically as non-benign Skin Neoplasms from Jan 1980 to Sep 2007 were retrospectively retrospected. Clinical data of patients were collected and analyzed by statistical methods. There were 531 patients with non-benign Skin Neoplasms diagnosed from 1980 to 2007, including 302 men and 229 women. 414 non-benign Skin Neoplasms from epidermis took the 77.97% of all cases. Six important kinds of all had obviously difference in gender proportion. The difference of skin Paget's disease was the most significant. Vicariance of melanoma patient's age was highest in all cases. The most youngest patient was 13 years. The cases of non-benign and malignant Skin Neoplasms had been increasing in the past 26 years. Neoplasms from epidermis was the main non-benign Skin Neoplasms. There had significant difference in patient gender of extramammary Paget's disease between Chinese and Caucasian. We should pay close attention to probability which youngsters have melanoma.
To analyze the tumor biological character of extramammary Paget's disease by investigate the expression of mucins. The content of research included the histological source of extramammary Paget's disease, and specificity of mucins expression in extramammary Paget's disease, the value in diagnosis and treatment of mucins expression in extramammary Paget's disease, the relationship of mucins expression and lymphatic metastasis of extramammary Paget's disease. By analyzing the E-cadherin expression in extramammary Paget's disease, to discuss the mechanism in invasion and metastasis of Paget's cell. To investigate the activity of human telomerase reverse transcriptase in extramammary Paget's disease. The technique of common histological pathology, HE staining, and immunohistochemistry, hybridization in situ were took in our research. The data of experiment was analyze by statistical method. There were significant difference between extramammary Paget's disease group and contrast group in expression of mucins and E-cadherin. 25 cases of extramammary Paget's disease group had muc5AC expression. All of contrast group had E-cadherin expression, but they had the different expression intensity. The E-cadherin expression intensity in extramammary Paget's disease descended significantly than contrast group. Some cases had focus disappearance in epidermis. In our research, there weren't relation between lymphatic metastasis and expression fo mucins and E-cadherin, between lymphatic metastasis and human telomerase reverse transcriptase activity, between mucl and E-cadherin, between mucins and E-cadherin, between human telomerase reverse transcriptase activity and mucins, between human telomerase reverse transcriptase activity and E-cadherin. Muc5AC maybe one of tumor special protein in extramammary Paget's disease. Paget 's cell maybe from epidermis stem cell in basal cell layer. E-cadherin may be as the important character in extramammary Paget's disease. It's descending may be the reason of Paget's cell widespread. The relation between mucins, E-cadherin and human telomerase reverse transcriptase need continue to research, so as the relation between they and lymphatic metastasis.
引文
[1]赵辨主编,临床皮肤病学.第三版[M].江苏:江苏科学技术出版社,2001:1119.
[2]Martin D,James O,Allen S.Clinical Oncology[M].Peking:Scientific Publishing Agency,2001:1317 - 1359.
[3]高天文,孙东杰,李春英等.中国西部两医院1905例皮肤恶性肿瘤回顾分析.北京大学学报(医学版)[J].2004(36):469-472.
[4]吴昌辉,魏矿荣,蔡昌金等.中山市1970～1999年皮肤恶性肿瘤发病动态分析.华南预防医学[J],2004,308-310.
[5]William D James,Timothy G Berger,Dirk M Elston.Andrews' Diseases of the Skin Clinical Dermatology[M].Pa:WB Saunders Co,2006.
[6]Lloyd J,Flanagan AM.Mammary and extramammary Paget's disase.J Clin Pathol[J],2000,53(10):742-749.
[7]Quirm AM,Sienko A,Basrawala Z,et al.Extramammary Paget disease of the scrotum with features of Bowen disease.Arch Pathol Lab Med[J],2004,128(1):84-86.
[8]Willman JH,Golitz LE,Fitzpatrick JE.Vulvar clear cells of Toker:precursors of extramammary Paget's disease.Am J Dermatopathol[J],2005,27(3):185-188.
[9]Belousova IE,Kazakov DV,Michal M,et al.Vulvar toker cells:the long-awaited missing link:a proposal for an origin-based histogenetic classification of extramammary paget disease.Am J Dermatopathol[J],2006,28(1):84-86.
[10]Liu H,Urabe K,Uchi H,et al.Expression and prognostic significance of Stat5a and E-cadherin in extramammary Paget's disease.J Cutan Pathol[J].2007,34(1):33-38.
[11]Choi YD,Cho NH,Park YS,et al.Lymphovascular and marginal invasion as useful prognostic indicators and the role of c-erbB-2 in patients with male extramammary Paget's disease:a study of 31 patients.J Urol[J].2005,174(2):561-565.
[12]Tsutsumida A,Yamamoto Y,Minakawa H,et al.Indications for lymph node dissection in the treatment of extramammary Paget's disease.Dermatol Surg[J].2003,29(1):21-24.
[13]O'Connor WJ,Lim KK,Zalla MJ,et al.Comparison of Mohs Micrographic Surgery and Wide Excision for Extramammary Paget's Disease.Dermatol Surg[J].2003,29(7):723-727.
[14]Hendi A,Brodland DG,Zitelli JA.Extramammary Paget's disease:surgical treatment with Mohs micrographic surgery.J Am Acad Dermatol[J].2004,51(5):767-773.
[15]Yoshii N,Kitajima S,Y onezawa S,et al.Expression of mucin core proteins in extramammary Paget's disease[J].Pathol Int,2002,52(5-6):390-399.
[16]Leroy X,Buisine MP,Leteurtre E,et al.MUC1(EMA):A key molecule of carcinogenesis? Ann Pathol[J].2006,26(4):257-266.
[17]张立新,李春海.MUC1粘蛋白的免疫生物学作用及其在肿瘤生物学治疗中的应用.中国肿瘤生物治疗杂志[J].2000,7(3):165-170.
[18]Kuan SF,Montag AG,Hart J,et al.Differential expression of mucin genes in mammary and extramammary Paget's disease.Am J Surg Pathol[J].2001,25(12):1469-1477.
[19]Kondo Y,Kashima K,Daa T,et al.The ectopic expression of gastric mucin in extramammary and mammary Paget's disease.Am J Surg Pathol[J].2002,26(5):617-623.
[20]Conacci-Sorrell M,Zhurinsky J,Ben-Ze'ev A.The cadherin-eatenin adhesion system in signaling and cancer.J Clin Invest[J].2002,109(8):987-991.
[21]魏志平 李艳 刘彦群.E-钙黏蛋白和MMP-2在皮肤鳞状细胞癌中的表达及其意义.中国麻风皮肤病杂志[J].2004,4(23):274-276.
[22]Guzifiska-Ustymowicz K,Chetnik A,Kemona A.Effects of changes at the site of E-cadherin expression as an indicator of colon cancer aggressiveness.Rocz Akad Med Bialymst[J].2004,Suppl 1:70-72.
[23]只达石,蔡春友,王宁等.脑胶质瘤端粒酶活性特征研究[J].中华神经外科杂志,2000,16(3):177-179.
[24]梁虹,周心房,方春红等.端粒酶在鳞状细胞癌和Bowen病组织中的表达[J].中华皮肤科杂志,2004,37(2)86-87.
[25].Lai YL,Yang WG,Tsay PK,et al.Penoserotal Extrarnammary Paget's Disease:A Review of 33 Cases in a 20-Year Experience.Plast Reeonstr Stag[J], 2003,112(4):1017-1023.
[26]朱学骏,涂平编著.皮肤病的组织病理诊断[M].北京:北京医科大学出版社,2001年:252-253.
[27]何勤,涂平,马圣清等.皮肤恶性肿瘤及癌前病变707例统计分析.中华皮肤科杂志[J],2003,36:109.
[28]陈晓栋,方方,赵亮等.乳房外Paget病27例临床分析.中华皮肤科杂志[J].2001,34:453.
[29]DeVita Jr et al.Cancer:Principles & Practice of Oncology[M],2003:1478.
[30]Brainard JA,Hart WR.Proliferative Epidermal Lesions Associated With Anogenital Paget's Disease.Am J Surg Pathol[J].2000,24(4):543-552.
[31]王旷,纪元,侯英勇.部分粘液素及角蛋白在腺上皮肿瘤中的表达.实用肿瘤学杂志[J].2006,5(20):423-426.
[32]肖春卫,易永芬.MUC1、MUC2及MUC5AC在大肠黏液腺癌组织中的表达及意义,实用癌症杂志[J],2007,1(22):47-49.
[31]Liegl B,Leibl S,Gogg-Kamerer M,et al.Mammary and extramammary Paget's disease:an immunohistochemical study of 83 cases[J].Histopathology,2007,50(4):439-447.
[32]马慧群,冯捷,彭振辉.人表皮干细胞的研究进展.中国皮肤性病学杂志[J].2007,6(21):370-373.
[33]丁颖果,武玲慎,涂平.端粒酶逆转录酶在皮肤肿瘤原位表达水平的比较.中国皮肤性病学杂志[J].2004,18(18-10).
[34]岳志红,张正.端粒酶检测技术在肿瘤诊断中的应用.中华检验医学杂志[J].2004,27(7)476-478.
[1]Tebes S,Cardosi R,Hoffman M.Paget's disease of the vulva.Am.J Obstet.Gynecol[J].2002,187(2):281-283.
[2]Dionyssopoulos A,Mandekou-Lefaki I,Vakirlis E,et al.Extramammary Paget's disease:isolated localization on the groin—wide local excision with immediate reconstruction.Ann Surg Oncol[J].2006,13(9):1235-1240.
[3]Pierie JP,Choudry U,Muzikansky A,et al.Prognosis and management of extramammary Paget's disease and the association with secondary malignancies.J Am Coil Surg[J].2003,196(1):45-50.
[4]Bowen GM,White GL Jr,Gerwels JW..Mohs Micrographic Surgery.Am Fam Physician[J].2005,72(5);845-848.
[5]Hendi A,Brodland DG,Zitelli JA.Extramammary Paget's disease:surgical treatment with Mohs micrographic surgery.J Am Acad Dermatol[J].2004,51(5):767-773.
[6]O'Connor W J,Lim KK,Zalla MJ,et al.Comparison of Mohs Micrographic Surgery and Wide Excision for Extramammary Paget's Disease.Dermatol Surg[J].2003,29(7):723 -727.
[7]Barlow RJ,Ramnarain N,Smith N,et al.Excision of Selected Skin Tumours using Mohs' Micrographic Surgery with Horizontal Paraffin-embedded Sections.Br J Dermatol[J].1996,135(6):911-917.
[8]Fishman A,Lew S,Altaras M,et al.A 30s PAS stain for frozen section analysis of surgical margins of vulvectomy in Paget's disease.Eur J Gynaecol Oncol[J].1998,19(5):482-483.
[9]Por Yong-Chen,Tan Bien-Keem,Hong Soo-Wan,et al.Use of the Scrotal Remnant as a Tissue-Expanding Musculocutaneous Flap for Scrotal Reconstruction in Paget's Disease.Ann Plast Surg[J].2003,51(2):155-160.
[10]Appert DL,Otley CC,Phillips PK,et al.Role of multiple scouting biopsies before Mohs micrographic surgery for extramammary Paget's disease.Derrnatol Surg[J].2005,31(11 Pt 1):1417-1422.
[11]Lai Yung-Lung,Yang Wen-Guei,Tsay Pei-Kwei,et al.Penoscrotal Extramammary Paget's Disease: A Review of 33 Cases in a 20-Year Experience. Plast Reconstr Surg[J]. 2003,112(4): 1017-1023.
[12] Murata Y, Kumano K. Extramammary Paget's disease of the genitalia with clinically clear margins can be adequately resected with 1 cm margin.Eur J Dermatol[J]. 2005,15(3): 168-70.
[13] Arango O, Bielsa O, Lorente JA,et al.Hemiscrotectomy With Contralateral Testicular Transposition for Scrotal Cancer. J Urol[J] .2002,168(4, Part 1 of 2):1406-1407.
[14] Lee PK, Choi MS, Ahn ST,et al. Gluteal fold V-Y advancement flap for vulvar and vaginal reconstruction: a new flap. Plast Reconstr Surg[J]. 2006,118(2):401-6.
[15] de Hullu J A,Hollema H,Piers D A,et al. Sentinel Lymph Node Procedure Is Highly Accurate in Squamous Cell Carcinoma of the Vulva. J Clin Oncol[J]. 2000,18(15):2811 -2816.
[16] Kiyohara Y, Yoshikawa S, Fujiwara N,et al. Sentinel node navigation surgery in melanoma and non-melanoma malignant skin tumor. Gan To Kagaku Ryoho[J]. 2005,32(8): 1191-1194.
[17] Hatta N, Morita R, Yamada M,et al. Sentinel lymph node biopsy in patients with extramammary Paget's disease. Dermatol Surg[J]. 2004,30(10):1329-1334.
[18] Burrows NP.Jones DH.Hudson PM.e tal. Treatment of extramammary Paget's disease by radiotherapy. Br J Dermatol[J]. 1995,132(6):970-972.
[19] Besa P,Rich TA,Delclos L,et al. Extramammary Paget's disease of the perineal skin: role of radiotherapy. Int J Radiat Oncol Biol Phys[J].1992,24(1 ):73-78.
[20] Moreno-Arias GA, Conill C, Sola-Casas MA,et al.Radiotherapy for in situ extramammary Paget disease of the vulva. J Dermatolog Treat[J].2003,14(2):119-123.
[21] Guerrieri M, Back MR Extramammary Paget's disease: Role of radiation therapy. Australas Radiol[J]. 2002,46(2):204-208.
[22] Yamamoto R.Sakuragi N.Shirato H.et al. Radiotherapy with concurrent chemotherapy for vulvar adenocarcinoma associated with extramammary Paget's disease.Gynecol Oncol[J]. 2001,80(2):267-271.
[23] Brown RS, Lankester KJ, McCormack M,et al, Radiotherapy for perianal Paget's disease.Clin Oncol (R Coll Radiol) [J]. 2002,14(4):272-284.
[24] Morton, C,A.Brown, S.B,Collins, S,et al.Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol[J]. 2002,146(4):552-567.
[25] Shieh S, Dee AS, Cheney RT, et al.Photodynamic therapy for the treatment of extramammary Paget's disease. Br J Dermatol[J].2002,146(6):1000-1005.
[26] Zollo JD, Zeitouni NC.The Roswell Park Cancer Institute experience with extramammary Paget's disease.Br J Dermatol[J]. 2000,142(1):59-65.
[27] Berman B, Perez O A, Zell D.Immunological strategies to fight skin cancer. Skin Therapy Lett[J]. 2006,11(5): 1-7.
[28] Gupta AK, Cherman AM, Tyring SK.Viral and nonviral uses of imiquimod: a review. J Cutan Med Surg[J]. 2004,8(5):338-352.
[29] Cohen PR, Schulze KE, Tschen JA, et al. Treatment of extramammary Paget disease with topical imiquimod cream: case report and literature review.South Med J[J]. 2006,99(4):396-402.
[30] Mirer E, El Sayed F, Ammoury A, et al. Treatment of mammary and extramammary Paget's skin disease with topical imiquimod. J Dermatolog Treat[J]. 2006,17(3):167-71.
[31] Kariya K, Tsuji T, Schwartz RA.Trial of low-dose 5-fluorouracil/cisplatin therapy for advanced extramammary Paget's disease. Dermatol Surg[J].2004,30(2 Pt 2):341-344.
[32] Onishi I, Kamata T, Hayashi H, et al. A case of vulval extramammary Paget'sdisease associated with pancreatic cancer that was successfully treated with chemotherapy. Gan to Kagaku Ryoho[J]. 2002,29(11):1973-1976.
[33] Oguchi S, Kaneko M, Uhara H, et al. Docetaxel induced durable response in advanced extramammary Paget's disease: a case report. J Dermatol[J]. 2002,29(1 ):33-37.
[34] Mochitomi Y, Sakamoto R, Gushi A, et al. Extramammary Paget's disease/carcinoma successfully treated with a combination chemotherapy: report of two cases. J Dermatol[J]. 2005,32(8):632-637.
[35] Watanabe Y, Hoshiai H,Ueda H,et al.Low-dose mitomycin C, etoposide, and cisplatin for invasive vulvar Paget's disease.Int J Gynecol Cancer[J].2002,12(3):304-307.
[36]Kuan SF,Montag AG,Hart J,et al.Differential Expression of Mucin Genes in Mammary and Extramammary Paget's Disease.Am J Surg Pathol[J].2001,25(12):1469-1477
[37]Brainard JA,Hart WR.Proliferative Epidermal Lesions Associated With Anogenital Paget's Disease.Am J Surg PathoI[J].2000,24(4):543-552.
[38]陈晓栋,方方,赵亮等.乳房外Paget病27例临床分析.中华皮肤科杂志[J].2001,34:453.
[39]Kondo Y,Kashima K,Daa T,et al.The Ectopic Expression of Gastric Mucin in Extramammary and Mammary Paget's Disease.Am J Surg Pathol[J].2002,26(5):617-623.
[40]Choi YD,Cho NH,Park YS,et al.Lymphovascular And Marginal Invasion As Useful Prognostic Indicators And The Role Of C-Erbb-2 In Patients With Male Extramammary Paget's Disease:A Study Of 31 Patients.J Urol[J].2005,174(4 Pt 1):1505.
[41]Hatta N.Extramammary Paget's disease.Gan To Kagaku Ryoho[J].2006,33(10):1404-1407.
[2]Martin D,James O,Allen S.Clinical Oncology[M].Peking:Scientific Publishing Agency,2001:1317 - 1359.
[3]高天文,孙东杰,李春英等.中国西部两医院1905例皮肤恶性肿瘤回顾分析.北京大学学报(医学版)[J].2004(36):469-472.
[4]吴昌辉,魏矿荣,蔡昌金等.中山市1970～1999年皮肤恶性肿瘤发病动态分析.华南预防医学[J],2004,308-310.
[5]William D James,Timothy G Berger,Dirk M Elston.Andrews' Diseases of the Skin Clinical Dermatology[M].Pa:WB Saunders Co,2006.
[6]Lloyd J,Flanagan AM.Mammary and extramammary Paget's disase.J Clin Pathol[J],2000,53(10):742-749.
[7]Quirm AM,Sienko A,Basrawala Z,et al.Extramammary Paget disease of the scrotum with features of Bowen disease.Arch Pathol Lab Med[J],2004,128(1):84-86.
[8]Willman JH,Golitz LE,Fitzpatrick JE.Vulvar clear cells of Toker:precursors of extramammary Paget's disease.Am J Dermatopathol[J],2005,27(3):185-188.
[9]Belousova IE,Kazakov DV,Michal M,et al.Vulvar toker cells:the long-awaited missing link:a proposal for an origin-based histogenetic classification of extramammary paget disease.Am J Dermatopathol[J],2006,28(1):84-86.
[10]Liu H,Urabe K,Uchi H,et al.Expression and prognostic significance of Stat5a and E-cadherin in extramammary Paget's disease.J Cutan Pathol[J].2007,34(1):33-38.
[11]Choi YD,Cho NH,Park YS,et al.Lymphovascular and marginal invasion as useful prognostic indicators and the role of c-erbB-2 in patients with male extramammary Paget's disease:a study of 31 patients.J Urol[J].2005,174(2):561-565.
[12]Tsutsumida A,Yamamoto Y,Minakawa H,et al.Indications for lymph node dissection in the treatment of extramammary Paget's disease.Dermatol Surg[J].2003,29(1):21-24.
[13]O'Connor WJ,Lim KK,Zalla MJ,et al.Comparison of Mohs Micrographic Surgery and Wide Excision for Extramammary Paget's Disease.Dermatol Surg[J].2003,29(7):723-727.
[14]Hendi A,Brodland DG,Zitelli JA.Extramammary Paget's disease:surgical treatment with Mohs micrographic surgery.J Am Acad Dermatol[J].2004,51(5):767-773.
[15]Yoshii N,Kitajima S,Y onezawa S,et al.Expression of mucin core proteins in extramammary Paget's disease[J].Pathol Int,2002,52(5-6):390-399.
[16]Leroy X,Buisine MP,Leteurtre E,et al.MUC1(EMA):A key molecule of carcinogenesis? Ann Pathol[J].2006,26(4):257-266.
[17]张立新,李春海.MUC1粘蛋白的免疫生物学作用及其在肿瘤生物学治疗中的应用.中国肿瘤生物治疗杂志[J].2000,7(3):165-170.
[18]Kuan SF,Montag AG,Hart J,et al.Differential expression of mucin genes in mammary and extramammary Paget's disease.Am J Surg Pathol[J].2001,25(12):1469-1477.
[19]Kondo Y,Kashima K,Daa T,et al.The ectopic expression of gastric mucin in extramammary and mammary Paget's disease.Am J Surg Pathol[J].2002,26(5):617-623.
[20]Conacci-Sorrell M,Zhurinsky J,Ben-Ze'ev A.The cadherin-eatenin adhesion system in signaling and cancer.J Clin Invest[J].2002,109(8):987-991.
[21]魏志平 李艳 刘彦群.E-钙黏蛋白和MMP-2在皮肤鳞状细胞癌中的表达及其意义.中国麻风皮肤病杂志[J].2004,4(23):274-276.
[22]Guzifiska-Ustymowicz K,Chetnik A,Kemona A.Effects of changes at the site of E-cadherin expression as an indicator of colon cancer aggressiveness.Rocz Akad Med Bialymst[J].2004,Suppl 1:70-72.
[23]只达石,蔡春友,王宁等.脑胶质瘤端粒酶活性特征研究[J].中华神经外科杂志,2000,16(3):177-179.
[24]梁虹,周心房,方春红等.端粒酶在鳞状细胞癌和Bowen病组织中的表达[J].中华皮肤科杂志,2004,37(2)86-87.
[25].Lai YL,Yang WG,Tsay PK,et al.Penoserotal Extrarnammary Paget's Disease:A Review of 33 Cases in a 20-Year Experience.Plast Reeonstr Stag[J], 2003,112(4):1017-1023.
[26]朱学骏,涂平编著.皮肤病的组织病理诊断[M].北京:北京医科大学出版社,2001年:252-253.
[27]何勤,涂平,马圣清等.皮肤恶性肿瘤及癌前病变707例统计分析.中华皮肤科杂志[J],2003,36:109.
[28]陈晓栋,方方,赵亮等.乳房外Paget病27例临床分析.中华皮肤科杂志[J].2001,34:453.
[29]DeVita Jr et al.Cancer:Principles & Practice of Oncology[M],2003:1478.
[30]Brainard JA,Hart WR.Proliferative Epidermal Lesions Associated With Anogenital Paget's Disease.Am J Surg Pathol[J].2000,24(4):543-552.
[31]王旷,纪元,侯英勇.部分粘液素及角蛋白在腺上皮肿瘤中的表达.实用肿瘤学杂志[J].2006,5(20):423-426.
[32]肖春卫,易永芬.MUC1、MUC2及MUC5AC在大肠黏液腺癌组织中的表达及意义,实用癌症杂志[J],2007,1(22):47-49.
[31]Liegl B,Leibl S,Gogg-Kamerer M,et al.Mammary and extramammary Paget's disease:an immunohistochemical study of 83 cases[J].Histopathology,2007,50(4):439-447.
[32]马慧群,冯捷,彭振辉.人表皮干细胞的研究进展.中国皮肤性病学杂志[J].2007,6(21):370-373.
[33]丁颖果,武玲慎,涂平.端粒酶逆转录酶在皮肤肿瘤原位表达水平的比较.中国皮肤性病学杂志[J].2004,18(18-10).
[34]岳志红,张正.端粒酶检测技术在肿瘤诊断中的应用.中华检验医学杂志[J].2004,27(7)476-478.
[1]Tebes S,Cardosi R,Hoffman M.Paget's disease of the vulva.Am.J Obstet.Gynecol[J].2002,187(2):281-283.
[2]Dionyssopoulos A,Mandekou-Lefaki I,Vakirlis E,et al.Extramammary Paget's disease:isolated localization on the groin—wide local excision with immediate reconstruction.Ann Surg Oncol[J].2006,13(9):1235-1240.
[3]Pierie JP,Choudry U,Muzikansky A,et al.Prognosis and management of extramammary Paget's disease and the association with secondary malignancies.J Am Coil Surg[J].2003,196(1):45-50.
[4]Bowen GM,White GL Jr,Gerwels JW..Mohs Micrographic Surgery.Am Fam Physician[J].2005,72(5);845-848.
[5]Hendi A,Brodland DG,Zitelli JA.Extramammary Paget's disease:surgical treatment with Mohs micrographic surgery.J Am Acad Dermatol[J].2004,51(5):767-773.
[6]O'Connor W J,Lim KK,Zalla MJ,et al.Comparison of Mohs Micrographic Surgery and Wide Excision for Extramammary Paget's Disease.Dermatol Surg[J].2003,29(7):723 -727.
[7]Barlow RJ,Ramnarain N,Smith N,et al.Excision of Selected Skin Tumours using Mohs' Micrographic Surgery with Horizontal Paraffin-embedded Sections.Br J Dermatol[J].1996,135(6):911-917.
[8]Fishman A,Lew S,Altaras M,et al.A 30s PAS stain for frozen section analysis of surgical margins of vulvectomy in Paget's disease.Eur J Gynaecol Oncol[J].1998,19(5):482-483.
[9]Por Yong-Chen,Tan Bien-Keem,Hong Soo-Wan,et al.Use of the Scrotal Remnant as a Tissue-Expanding Musculocutaneous Flap for Scrotal Reconstruction in Paget's Disease.Ann Plast Surg[J].2003,51(2):155-160.
[10]Appert DL,Otley CC,Phillips PK,et al.Role of multiple scouting biopsies before Mohs micrographic surgery for extramammary Paget's disease.Derrnatol Surg[J].2005,31(11 Pt 1):1417-1422.
[11]Lai Yung-Lung,Yang Wen-Guei,Tsay Pei-Kwei,et al.Penoscrotal Extramammary Paget's Disease: A Review of 33 Cases in a 20-Year Experience. Plast Reconstr Surg[J]. 2003,112(4): 1017-1023.
[12] Murata Y, Kumano K. Extramammary Paget's disease of the genitalia with clinically clear margins can be adequately resected with 1 cm margin.Eur J Dermatol[J]. 2005,15(3): 168-70.
[13] Arango O, Bielsa O, Lorente JA,et al.Hemiscrotectomy With Contralateral Testicular Transposition for Scrotal Cancer. J Urol[J] .2002,168(4, Part 1 of 2):1406-1407.
[14] Lee PK, Choi MS, Ahn ST,et al. Gluteal fold V-Y advancement flap for vulvar and vaginal reconstruction: a new flap. Plast Reconstr Surg[J]. 2006,118(2):401-6.
[15] de Hullu J A,Hollema H,Piers D A,et al. Sentinel Lymph Node Procedure Is Highly Accurate in Squamous Cell Carcinoma of the Vulva. J Clin Oncol[J]. 2000,18(15):2811 -2816.
[16] Kiyohara Y, Yoshikawa S, Fujiwara N,et al. Sentinel node navigation surgery in melanoma and non-melanoma malignant skin tumor. Gan To Kagaku Ryoho[J]. 2005,32(8): 1191-1194.
[17] Hatta N, Morita R, Yamada M,et al. Sentinel lymph node biopsy in patients with extramammary Paget's disease. Dermatol Surg[J]. 2004,30(10):1329-1334.
[18] Burrows NP.Jones DH.Hudson PM.e tal. Treatment of extramammary Paget's disease by radiotherapy. Br J Dermatol[J]. 1995,132(6):970-972.
[19] Besa P,Rich TA,Delclos L,et al. Extramammary Paget's disease of the perineal skin: role of radiotherapy. Int J Radiat Oncol Biol Phys[J].1992,24(1 ):73-78.
[20] Moreno-Arias GA, Conill C, Sola-Casas MA,et al.Radiotherapy for in situ extramammary Paget disease of the vulva. J Dermatolog Treat[J].2003,14(2):119-123.
[21] Guerrieri M, Back MR Extramammary Paget's disease: Role of radiation therapy. Australas Radiol[J]. 2002,46(2):204-208.
[22] Yamamoto R.Sakuragi N.Shirato H.et al. Radiotherapy with concurrent chemotherapy for vulvar adenocarcinoma associated with extramammary Paget's disease.Gynecol Oncol[J]. 2001,80(2):267-271.
[23] Brown RS, Lankester KJ, McCormack M,et al, Radiotherapy for perianal Paget's disease.Clin Oncol (R Coll Radiol) [J]. 2002,14(4):272-284.
[24] Morton, C,A.Brown, S.B,Collins, S,et al.Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol[J]. 2002,146(4):552-567.
[25] Shieh S, Dee AS, Cheney RT, et al.Photodynamic therapy for the treatment of extramammary Paget's disease. Br J Dermatol[J].2002,146(6):1000-1005.
[26] Zollo JD, Zeitouni NC.The Roswell Park Cancer Institute experience with extramammary Paget's disease.Br J Dermatol[J]. 2000,142(1):59-65.
[27] Berman B, Perez O A, Zell D.Immunological strategies to fight skin cancer. Skin Therapy Lett[J]. 2006,11(5): 1-7.
[28] Gupta AK, Cherman AM, Tyring SK.Viral and nonviral uses of imiquimod: a review. J Cutan Med Surg[J]. 2004,8(5):338-352.
[29] Cohen PR, Schulze KE, Tschen JA, et al. Treatment of extramammary Paget disease with topical imiquimod cream: case report and literature review.South Med J[J]. 2006,99(4):396-402.
[30] Mirer E, El Sayed F, Ammoury A, et al. Treatment of mammary and extramammary Paget's skin disease with topical imiquimod. J Dermatolog Treat[J]. 2006,17(3):167-71.
[31] Kariya K, Tsuji T, Schwartz RA.Trial of low-dose 5-fluorouracil/cisplatin therapy for advanced extramammary Paget's disease. Dermatol Surg[J].2004,30(2 Pt 2):341-344.
[32] Onishi I, Kamata T, Hayashi H, et al. A case of vulval extramammary Paget'sdisease associated with pancreatic cancer that was successfully treated with chemotherapy. Gan to Kagaku Ryoho[J]. 2002,29(11):1973-1976.
[33] Oguchi S, Kaneko M, Uhara H, et al. Docetaxel induced durable response in advanced extramammary Paget's disease: a case report. J Dermatol[J]. 2002,29(1 ):33-37.
[34] Mochitomi Y, Sakamoto R, Gushi A, et al. Extramammary Paget's disease/carcinoma successfully treated with a combination chemotherapy: report of two cases. J Dermatol[J]. 2005,32(8):632-637.
[35] Watanabe Y, Hoshiai H,Ueda H,et al.Low-dose mitomycin C, etoposide, and cisplatin for invasive vulvar Paget's disease.Int J Gynecol Cancer[J].2002,12(3):304-307.
[36]Kuan SF,Montag AG,Hart J,et al.Differential Expression of Mucin Genes in Mammary and Extramammary Paget's Disease.Am J Surg Pathol[J].2001,25(12):1469-1477
[37]Brainard JA,Hart WR.Proliferative Epidermal Lesions Associated With Anogenital Paget's Disease.Am J Surg PathoI[J].2000,24(4):543-552.
[38]陈晓栋,方方,赵亮等.乳房外Paget病27例临床分析.中华皮肤科杂志[J].2001,34:453.
[39]Kondo Y,Kashima K,Daa T,et al.The Ectopic Expression of Gastric Mucin in Extramammary and Mammary Paget's Disease.Am J Surg Pathol[J].2002,26(5):617-623.
[40]Choi YD,Cho NH,Park YS,et al.Lymphovascular And Marginal Invasion As Useful Prognostic Indicators And The Role Of C-Erbb-2 In Patients With Male Extramammary Paget's Disease:A Study Of 31 Patients.J Urol[J].2005,174(4 Pt 1):1505.
[41]Hatta N.Extramammary Paget's disease.Gan To Kagaku Ryoho[J].2006,33(10):1404-1407.